Global Certolizumab Pegol Market Growth (Status and Outlook) 2022-2028
- LP 4798512
- 63 Pages
- January 2022
- Pharmaceuticals
The United States Certolizumab Pegol market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Certolizumab Pegol market, reaching US$ million by the year 2028. As for the Europe Certolizumab Pegol landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Certolizumab Pegol players cover UCB, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Certolizumab Pegol market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Single-dose vial
Single-dose prefilled syringe
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Crohn’s disease
Active rheumatoid arthritis
Active psoriatic arthritis
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
UCB
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Certolizumab Pegol Market Size 2017-2028
2.1.2 Certolizumab Pegol Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Certolizumab Pegol Segment by Type
2.2.1 Single-dose vial
2.2.2 Single-dose prefilled syringe
2.3 Certolizumab Pegol Market Size by Type
2.3.1 Certolizumab Pegol Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Certolizumab Pegol Market Size Market Share by Type (2017-2022)
2.4 Certolizumab Pegol Segment by Application
2.4.1 Crohn’s disease
2.4.2 Active rheumatoid arthritis
2.4.3 Active psoriatic arthritis
2.5 Certolizumab Pegol Market Size by Application
2.5.1 Certolizumab Pegol Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Certolizumab Pegol Market Size Market Share by Application (2017-2022)
3 Certolizumab Pegol Market Size by Player
3.1 Certolizumab Pegol Market Size Market Share by Players
3.1.1 Global Certolizumab Pegol Revenue by Players (2020-2022)
3.1.2 Global Certolizumab Pegol Revenue Market Share by Players (2020-2022)
3.2 Global Certolizumab Pegol Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Certolizumab Pegol by Regions
4.1 Certolizumab Pegol Market Size by Regions (2017-2022)
4.2 Americas Certolizumab Pegol Market Size Growth (2017-2022)
4.3 APAC Certolizumab Pegol Market Size Growth (2017-2022)
4.4 Europe Certolizumab Pegol Market Size Growth (2017-2022)
4.5 Middle East & Africa Certolizumab Pegol Market Size Growth (2017-2022)
5 Americas
5.1 Americas Certolizumab Pegol Market Size by Country (2017-2022)
5.2 Americas Certolizumab Pegol Market Size by Type (2017-2022)
5.3 Americas Certolizumab Pegol Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Certolizumab Pegol Market Size by Region (2017-2022)
6.2 APAC Certolizumab Pegol Market Size by Type (2017-2022)
6.3 APAC Certolizumab Pegol Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Certolizumab Pegol by Country (2017-2022)
7.2 Europe Certolizumab Pegol Market Size by Type (2017-2022)
7.3 Europe Certolizumab Pegol Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Certolizumab Pegol by Region (2017-2022)
8.2 Middle East & Africa Certolizumab Pegol Market Size by Type (2017-2022)
8.3 Middle East & Africa Certolizumab Pegol Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Certolizumab Pegol Market Forecast
10.1 Global Certolizumab Pegol Forecast by Regions (2023-2028)
10.1.1 Global Certolizumab Pegol Forecast by Regions (2023-2028)
10.1.2 Americas Certolizumab Pegol Forecast
10.1.3 APAC Certolizumab Pegol Forecast
10.1.4 Europe Certolizumab Pegol Forecast
10.1.5 Middle East & Africa Certolizumab Pegol Forecast
10.2 Americas Certolizumab Pegol Forecast by Country (2023-2028)
10.2.1 United States Certolizumab Pegol Market Forecast
10.2.2 Canada Certolizumab Pegol Market Forecast
10.2.3 Mexico Certolizumab Pegol Market Forecast
10.2.4 Brazil Certolizumab Pegol Market Forecast
10.3 APAC Certolizumab Pegol Forecast by Region (2023-2028)
10.3.1 China Certolizumab Pegol Market Forecast
10.3.2 Japan Certolizumab Pegol Market Forecast
10.3.3 Korea Certolizumab Pegol Market Forecast
10.3.4 Southeast Asia Certolizumab Pegol Market Forecast
10.3.5 India Certolizumab Pegol Market Forecast
10.3.6 Australia Certolizumab Pegol Market Forecast
10.4 Europe Certolizumab Pegol Forecast by Country (2023-2028)
10.4.1 Germany Certolizumab Pegol Market Forecast
10.4.2 France Certolizumab Pegol Market Forecast
10.4.3 UK Certolizumab Pegol Market Forecast
10.4.4 Italy Certolizumab Pegol Market Forecast
10.4.5 Russia Certolizumab Pegol Market Forecast
10.5 Middle East & Africa Certolizumab Pegol Forecast by Region (2023-2028)
10.5.1 Egypt Certolizumab Pegol Market Forecast
10.5.2 South Africa Certolizumab Pegol Market Forecast
10.5.3 Israel Certolizumab Pegol Market Forecast
10.5.4 Turkey Certolizumab Pegol Market Forecast
10.5.5 GCC Countries Certolizumab Pegol Market Forecast
10.6 Global Certolizumab Pegol Forecast by Type (2023-2028)
10.7 Global Certolizumab Pegol Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 UCB
11.1.1 UCB Company Information
11.1.2 UCB Certolizumab Pegol Product Offered
11.1.3 UCB Certolizumab Pegol Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 UCB Main Business Overview
11.1.5 UCB Latest Developments
12 Research Findings and Conclusion
Table 1. Certolizumab Pegol Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Single-dose vial
Table 3. Major Players of Single-dose prefilled syringe
Table 4. Certolizumab Pegol Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Certolizumab Pegol Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Certolizumab Pegol Market Size Market Share by Type (2017-2022)
Table 7. Certolizumab Pegol Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Certolizumab Pegol Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Certolizumab Pegol Market Size Market Share by Application (2017-2022)
Table 10. Global Certolizumab Pegol Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Certolizumab Pegol Revenue Market Share by Player (2020-2022)
Table 12. Certolizumab Pegol Key Players Head office and Products Offered
Table 13. Certolizumab Pegol Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Certolizumab Pegol Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Certolizumab Pegol Market Size Market Share by Regions (2017-2022)
Table 18. Americas Certolizumab Pegol Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Certolizumab Pegol Market Size Market Share by Country (2017-2022)
Table 20. Americas Certolizumab Pegol Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Certolizumab Pegol Market Size Market Share by Type (2017-2022)
Table 22. Americas Certolizumab Pegol Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Certolizumab Pegol Market Size Market Share by Application (2017-2022)
Table 24. APAC Certolizumab Pegol Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Certolizumab Pegol Market Size Market Share by Region (2017-2022)
Table 26. APAC Certolizumab Pegol Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Certolizumab Pegol Market Size Market Share by Type (2017-2022)
Table 28. APAC Certolizumab Pegol Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Certolizumab Pegol Market Size Market Share by Application (2017-2022)
Table 30. Europe Certolizumab Pegol Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Certolizumab Pegol Market Size Market Share by Country (2017-2022)
Table 32. Europe Certolizumab Pegol Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Certolizumab Pegol Market Size Market Share by Type (2017-2022)
Table 34. Europe Certolizumab Pegol Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Certolizumab Pegol Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Certolizumab Pegol Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Certolizumab Pegol Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Certolizumab Pegol Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Certolizumab Pegol Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Certolizumab Pegol Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Certolizumab Pegol Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Certolizumab Pegol
Table 43. Key Market Challenges & Risks of Certolizumab Pegol
Table 44. Key Industry Trends of Certolizumab Pegol
Table 45. Global Certolizumab Pegol Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Certolizumab Pegol Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Certolizumab Pegol Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Certolizumab Pegol Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Certolizumab Pegol Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Certolizumab Pegol Market Size Market Share Forecast by Application (2023-2028)
Table 51. UCB Details, Company Type, Certolizumab Pegol Area Served and Its Competitors
Table 52. UCB Certolizumab Pegol Product Offered
Table 53. UCB Certolizumab Pegol Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. UCB Main Business
Table 55. UCB Latest Developments
List of Figures
Figure 1. Certolizumab Pegol Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Certolizumab Pegol Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Certolizumab Pegol Market Size Market Share by Type in 2021
Figure 7. Certolizumab Pegol in Crohn’s disease
Figure 8. Global Certolizumab Pegol Market: Crohn’s disease (2017-2022) & ($ Millions)
Figure 9. Certolizumab Pegol in Active rheumatoid arthritis
Figure 10. Global Certolizumab Pegol Market: Active rheumatoid arthritis (2017-2022) & ($ Millions)
Figure 11. Certolizumab Pegol in Active psoriatic arthritis
Figure 12. Global Certolizumab Pegol Market: Active psoriatic arthritis (2017-2022) & ($ Millions)
Figure 13. Global Certolizumab Pegol Market Size Market Share by Application in 2021
Figure 14. Global Certolizumab Pegol Revenue Market Share by Player in 2021
Figure 15. Global Certolizumab Pegol Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Certolizumab Pegol Market Size 2017-2022 ($ Millions)
Figure 17. APAC Certolizumab Pegol Market Size 2017-2022 ($ Millions)
Figure 18. Europe Certolizumab Pegol Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Certolizumab Pegol Market Size 2017-2022 ($ Millions)
Figure 20. Americas Certolizumab Pegol Value Market Share by Country in 2021
Figure 21. Americas Certolizumab Pegol Consumption Market Share by Type in 2021
Figure 22. Americas Certolizumab Pegol Market Size Market Share by Application in 2021
Figure 23. United States Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Certolizumab Pegol Market Size Market Share by Region in 2021
Figure 28. APAC Certolizumab Pegol Market Size Market Share by Application in 2021
Figure 29. China Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Certolizumab Pegol Market Size Market Share by Country in 2021
Figure 36. Europe Certolizumab Pegol Market Size Market Share by Type in 2021
Figure 37. Europe Certolizumab Pegol Market Size Market Share by Application in 2021
Figure 38. Germany Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Certolizumab Pegol Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Certolizumab Pegol Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Certolizumab Pegol Market Size Market Share by Application in 2021
Figure 46. Egypt Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Certolizumab Pegol Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 52. APAC Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 53. Europe Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 55. United States Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 56. Canada Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 59. China Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 60. Japan Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 61. Korea Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 63. India Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 64. Australia Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 65. Germany Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 66. France Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 67. UK Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 68. Italy Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 69. Russia Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 70. Spain Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 73. Israel Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Certolizumab Pegol Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
